Risk of heart failure in elderly patients with atrial fibrillation and diabetes taking different oral anticoagulants: a nationwide cohort study
Abstract Background Heart failure (HF) is a critical complication in elderly patients with atrial fibrillation (AF) and diabetes mellitus (DM). Recent preclinical studies suggested that non-vitamin K antagonist oral anticoagulants (NOACs) can potentially suppress the progression of cardiac fibrosis...
Main Authors: | Shu-Man Lin, Peter Pin-Sung Liu, Yu-Kang Tu, Edward Chia-Cheng Lai, Jih-I Yeh, Jin-Yi Hsu, Kashif M. Munir, Carol Chiung-Hui Peng, Huei-Kai Huang, Ching-Hui Loh |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2023-01-01
|
Series: | Cardiovascular Diabetology |
Subjects: | |
Online Access: | https://doi.org/10.1186/s12933-022-01688-1 |
Similar Items
-
New oral anticoagulants for atrial fibrillation
by: Yuliana Yakobus
Published: (2017-06-01) -
Lower Risk of Dementia in Patients With Atrial Fibrillation Taking Non‐Vitamin K Antagonist Oral Anticoagulants: A Nationwide Population‐Based Cohort Study
by: Jin‐Yi Hsu, et al.
Published: (2021-03-01) -
Prevalence of oral anticoagulation in atrial fibrillation
by: Eduardo Bartholomay, et al.
Published: (2014-09-01) -
ANTICOAGULATION CONTROL AMONG PATIENTS WITH ATRIAL FIBRILLATION
by: Amer Rauf, et al.
Published: (2020-12-01) -
Oral anticoagulant decreases stroke recurrence in patients with atrial fibrillation detected after stroke
by: Jin-Yi Hsu, et al.
Published: (2022-07-01)